Coherus Oncology, Inc. (CHRS)

Typically moves ±10.33% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Coherus Oncology, Inc. (CHRS) has reported earnings 22 times since May 06, 2021. The stock moves an average of ±10.33% the day after reporting, closing higher 40.9% of the time. Its largest post-earnings gain was +17.74% (Aug 02, 2023) and its largest decline was -30.23% (Nov 06, 2023). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How CHRS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±10.33%

Positive %

40.9%

Negative %

59.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☽ POST	-12.76%	open_in_new
May 11, 2026	☽ POST	-11.86%	open_in_new
Mar 09, 2026	☽ POST	+1.04%	open_in_new
Nov 06, 2025	☽ POST	-10.07%	open_in_new
Aug 07, 2025	☽ POST	-7.13%	open_in_new
May 12, 2025	☽ POST	-19.12%	open_in_new
Mar 10, 2025	☽ POST	+0.96%	open_in_new
Nov 06, 2024	☽ POST	+13.26%	open_in_new
Aug 08, 2024	☽ POST	+10.85%	open_in_new
May 09, 2024	☽ POST	-10.38%	open_in_new
Mar 13, 2024	☽ POST	-5.65%	open_in_new
Nov 06, 2023	☽ POST	-30.23%	open_in_new
Aug 02, 2023	☽ POST	+17.74%	open_in_new
May 08, 2023	☽ POST	-27.4%	open_in_new
Mar 06, 2023	☽ POST	+7.83%	open_in_new
Nov 08, 2022	☽ POST	-12.27%	open_in_new
Aug 04, 2022	☽ POST	+11.81%	open_in_new
May 05, 2022	☽ POST	-4.42%	open_in_new
Feb 17, 2022	☽ POST	-4.12%	open_in_new
Nov 08, 2021	☽ POST	+6.74%	open_in_new
Aug 05, 2021	☽ POST	+0.46%	open_in_new
May 06, 2021	☽ POST	-1.24%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.33%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$26460787

Total value held

Buying

14 added · 4 reduced

Blackrock, Inc.

$16804642 +15.81%

State Street Corp

$3335227 +2.43%

Northern Trust Corp

$1581259 +23.60%

Ubs Group Ag

$1064501 NEW BUY

Goldman Sachs Group Inc

$842905 -13.51%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
424B3	20260828	open_in_new SEC.gov
424B5	20260828	open_in_new SEC.gov
8-K	20260828	open_in_new SEC.gov
8-K	20260817	open_in_new SEC.gov
8-K	20260817	open_in_new SEC.gov
10-Q	20260805	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
S-8	20260805	open_in_new SEC.gov
SCHEDULE 13G	20260727	open_in_new SEC.gov
8-K	20260615	open_in_new SEC.gov

Frequently asked about CHRS earnings

When does Coherus Oncology, Inc. report earnings next? expand_more

Coherus Oncology, Inc. (CHRS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CHRS stock move after earnings? expand_more

Over 22 reports, CHRS has moved an average of ±10.33% the session after earnings, closing higher 40.9% of the time.

What was CHRS's biggest post-earnings move? expand_more

CHRS's largest post-earnings gain on record was +17.74% on Aug 02, 2023, and its largest decline was -30.23% on Nov 06, 2023.

Where can I find Coherus Oncology, Inc.'s SEC filings? expand_more

All of Coherus Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.